CA2717012A1 - Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases - Google Patents

Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases Download PDF

Info

Publication number
CA2717012A1
CA2717012A1 CA2717012A CA2717012A CA2717012A1 CA 2717012 A1 CA2717012 A1 CA 2717012A1 CA 2717012 A CA2717012 A CA 2717012A CA 2717012 A CA2717012 A CA 2717012A CA 2717012 A1 CA2717012 A1 CA 2717012A1
Authority
CA
Canada
Prior art keywords
glucuronide
beta
quercetin
heart
kaempferol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2717012A
Other languages
English (en)
French (fr)
Inventor
Anke Esperester
Stephan Nees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of CA2717012A1 publication Critical patent/CA2717012A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA2717012A 2008-03-06 2009-03-03 Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases Abandoned CA2717012A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008012909A DE102008012909A1 (de) 2008-03-06 2008-03-06 Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen
DE102008012909.7 2008-03-06
PCT/EP2009/052502 WO2009109573A1 (de) 2008-03-06 2009-03-03 Verwendung von flavonoidverbindungen für die propyhylaxe und therapie ischämischer oder entzündlicher herz- und kreislauferkrankungen

Publications (1)

Publication Number Publication Date
CA2717012A1 true CA2717012A1 (en) 2009-09-11

Family

ID=40600026

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2717012A Abandoned CA2717012A1 (en) 2008-03-06 2009-03-03 Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases

Country Status (6)

Country Link
US (2) US20110053874A1 (OSRAM)
EP (1) EP2268277A1 (OSRAM)
JP (1) JP2011527984A (OSRAM)
CA (1) CA2717012A1 (OSRAM)
DE (1) DE102008012909A1 (OSRAM)
WO (1) WO2009109573A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2482864C2 (ru) * 2007-08-31 2013-05-27 Бёрингер Ингельхайм Интернациональ Гмбх Пригодная для распыления композиция, содержащая экстракт из листьев красного винограда
DE102008012908A1 (de) * 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methode zum anti-inflammatorischen und anti-ödematösen Schutz von explantiertem biologischen Material bis zu seiner Transplantation in Patienten
MX368855B (es) 2012-10-11 2019-10-18 Armaron Bio Pty Ltd Compuestos de flavonoides novedosos y sus usos.
CN113398114B (zh) * 2021-05-28 2022-11-01 浙江大学智能创新药物研究院 3,7,8,4′-四羟基黄酮在制备抗心血管疾病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE271389T1 (de) * 1998-10-29 2004-08-15 Merck Patent Gmbh Zusammensetzung enthaltend eine mischung von bioflavonoiden
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
MXPA02011528A (es) * 2000-05-25 2003-04-25 Pharmaton Sa Metodo para mejorar la proteccion celular.
CN1197567C (zh) * 2002-10-21 2005-04-20 中国人民解放军第二军医大学 山奈酚衍生物用于制备防治脑血管疾病药物的用途
ATE468847T1 (de) 2002-12-31 2010-06-15 Boehringer Ingelheim Int Filmtablette mit extrakt aus roten weinblättern

Also Published As

Publication number Publication date
DE102008012909A1 (de) 2009-09-10
US20110053874A1 (en) 2011-03-03
EP2268277A1 (de) 2011-01-05
US20130109641A1 (en) 2013-05-02
JP2011527984A (ja) 2011-11-10
WO2009109573A1 (de) 2009-09-11

Similar Documents

Publication Publication Date Title
Dludla et al. Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos flavonoids and phenylpyruvic acid-2-O-β-D-glucoside
Lattanzio et al. Globe artichoke: A functional food and source of nutraceutical ingredients
Nijveldt et al. Flavonoids: a review of probable mechanisms of action and potential applications
Lockyer et al. Olive leaf phenolics and cardiovascular risk reduction: physiological effects and mechanisms of action
JP2001526658A (ja) 虚血の治療および／または予防を行う際の医薬組成物の使用
Bernatoniene et al. The effect of crataegus fruit extract and some of its flavonoids on mitochondrial oxidative phosphorylation in the heart
EP2814336A2 (en) Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia
NO339322B1 (no) Formuleringer inneholdende cynara scolymus og phaseolus vulgaris ekstrakter som er nyttige i behandlingen av fedme
JP5898825B2 (ja) 腸内有害菌低減剤、それを含む食品または医薬品
Masoodi et al. A comprehensive review on fruit Aristotelia chilensis (Maqui) for modern health: Towards a better understanding
US20060116333A1 (en) Composition for protecting organ, tissue or cell and utilization thereof
US20130109641A1 (en) Use of flavonoide compounds for the prophylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases
US10213450B2 (en) Combination of biologically active substances for treatment of hyperglycaemic disorders
ES2342018T3 (es) Metodo de tratamiento de afecciones inflamatorias usando extractos de maracuya.
US20020022061A1 (en) Use of cocoa procyanidins combined with acetylsalicilic acid as an anti-platelet therapy
Taie et al. Chemical composition and biological activities of two Solanum tuberosum cultivars grown in Egypt
Jafari-Khataylou et al. Troxerutin attenuates inflammatory response in lipopolysaccharide-induced sepsis in mice
WO2004096240A1 (en) Anthocyanins useful for the treatment of diabetes, cardiovascular disorders and to lower the risk of adverse effects of hormone replacement therapy
KR20140077483A (ko) 갯방풍 추출물을 포함하는 허혈성 뇌혈관 질환 예방 또는 개선용 조성물
Alzobair et al. Gentamicin induced damage in nephrotoxicity and hepatotoxicity in male rabbits: the protective effect of cinnamon
JP2007520431A (ja) 血糖降下用組成物
JP2009137920A (ja) グリコーゲンホスホリラーゼ阻害剤
WO2015160181A1 (ko) 황칠 추출물을 포함하는 혈관 평활근세포 이상 증식 및 이동성 질환 또는 혈관 내막증식 질환의 예방 또는 치료용 조성물
JP2014239699A (ja) 血中アディポネクチン量増加剤
JP2014240431A (ja) 腸内有害菌低減剤、それを含む食品または医薬品

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140304